Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
EXOC5 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC5, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC3L4 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC3L4, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
8 min read
EXOC3L2 Target Evaluation Report 2026: Biology, Validation, Competition, IP, and R&D Strategy
4 August 2026
A visual target evaluation report for EXOC3L2, generated in a PatSnap Life Sciences MCP-style workflow covering biology, validation evidence, clinical competition, IP signals, and R&D strategy.
Latest Hotspot
8 min read
Angle recession glaucoma Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Angle recession glaucoma indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Normal tension glaucoma Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Normal tension glaucoma indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Plateau iris syndrome Indication Strategy Report 2026: Rho kinase, Trials and Deals
3 August 2026
2026 Plateau iris syndrome indication strategy covering epidemiology, Rho kinase biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pigment dispersion syndrome Indication Strategy Report 2026: TYR, Trials and Deals
3 August 2026
2026 Pigment dispersion syndrome indication strategy covering epidemiology, TYR biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pseudoexfoliation syndrome Indication Strategy Report 2026: LOXL1, Trials and Deals
3 August 2026
2026 Pseudoexfoliation syndrome indication strategy covering epidemiology, LOXL1 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Orbital lymphangioma Indication Strategy Report 2026: PIK3CA, Trials and Deals
3 August 2026
2026 Orbital lymphangioma indication strategy covering epidemiology, PIK3CA biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Thyroid eye disease chronic inactive Indication Strategy Report 2026: IGF1R, Trials and Deals
3 August 2026
2026 Thyroid eye disease chronic inactive indication strategy covering epidemiology, IGF1R biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Idiopathic orbital inflammation Indication Strategy Report 2026: CD20, Trials and Deals
3 August 2026
2026 Idiopathic orbital inflammation indication strategy covering epidemiology, CD20 biology, active trials, transactions, unmet need, competition and market…